Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493450 | SCV000582819 | likely pathogenic | not provided | 2024-12-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26435059, 25895475, 21446023, 31692161, 36208030) |
Labcorp Genetics |
RCV000493450 | SCV002230676 | pathogenic | not provided | 2024-11-30 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 361 of the WFS1 protein (p.Thr361Ile). This variant is present in population databases (rs781575919, gnomAD 0.02%). This missense change has been observed in individuals with Wolfram syndrome (PMID: 21446023, 25895475, 31692161). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 430094). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt WFS1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005034035 | SCV005660218 | likely pathogenic | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2024-06-03 | criteria provided, single submitter | clinical testing |